Patent details

EP4252003 Title: ANALYTICAL METHOD FOR GLYCOCONJUGATES USING A CAPILLARY-BASED IMMUNOASSAY SYSTEM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
02/04/2025
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
08/04/2025
Unitary Effect Date:
05/03/2025
Unitary Effect Registration Date:
08/04/2025
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP4252003
SPC Number:
Creation Date:

Basic Information

Publication number:
EP4252003
WO Application Number:
IB2021061115
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP21819229.2
WO Publication Number:
WO2022113048
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
30/11/2021
Grant date:
05/03/2025
EP Publication Date:
04/10/2023
WO Publication Date:
02/06/2022
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/03/2025
EP B1 Publication Date:
05/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/11/2041
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/03/2025
 
 

 

Name:
Janssen Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, TITUSVILLE, NJ 08560, United States of America (US)

Inventor

1

Name:
MANI, Jan
Address:
3018 Bern, Switzerland (CH)

2

Name:
KRIEFTEWIRTH, Michael
Address:
3018 Bern, Switzerland (CH)

3

Name:
REBER, Vera
Address:
3018 Bern, Switzerland (CH)

4

Name:
BIANCHI, Joëlle
Address:
3018 Bern, Switzerland (CH)

5

Name:
PIANTA, Annalisa
Address:
3018 Bern, Switzerland (CH)

6

Name:
CHAKKUMKAL, Anish
Address:
2333 CN Leiden, Netherlands (NL)

7

Name:
GRIJPSTRA, Jan
Address:
2333 CN Leiden, Netherlands (NL)

8

Name:
KAGABO, Diane
Address:
2333 CN Leiden, Netherlands (NL)

Priority

Priority Patent Number:
20210768
Priority Date:
30/11/2020
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
G01N 33/561; G01N 33/569;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
19/25
Publication date:
07/05/2025
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
10/25
Publication date:
05/03/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202519
Publication date:
07/05/2025
Description:
Unitary Effect Request Receipt

2

Issue number:
202519
Publication date:
07/05/2025
Description:
Unitary Effect Request Acceptance

3

Issue number:
202510
Publication date:
05/03/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type